tirzepatide side effects heart rate and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Failure Management Unanticipated Adverse Events With Tirzepatide:

The SELECT trial builds on these results, showing that once-weekly semaglutide resulted in a 20% reduction in the primary composite endpoint of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with pre-existing cardiovascular disease and BMI 27kg/m 2

Unlike prescription GLP-1 drugs, Salo is available without doctor approval, needles, or medical monitoring

Im so much more confident in myself

These medications are still relatively new, so there is not much long-term data on them yet, but semaglutide has been around for a longer time, so we do have some research findings to share: One review on GLP1 medications reports that the evidence is limited on whether these drugs are linked to menstrual or fertility changes, but research is still ongoing

Reedtz-Runge for critical review of the manuscript

Annual Review of Pharmacology and Toxicology , 45, 51-88.